Write in a clean editor, then format for Therapeutic Advances in Cardiovascular Disease in one click — DocuGuru applies the official SAGE template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Therapeutic Advances in Cardiovascular Disease is a peer-reviewed journal published by SAGE, covering Blood Pressure and Hypertension Studies, Heart Failure Treatment and Management, Atrial Fibrillation Management and Outcomes.
| Publisher | SAGE |
|---|---|
| Reference style | Author–year (Harvard) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Therapeutic Advances in Cardiovascular Disease, 12(3), pp. 45–58.
Formats any DOI in Therapeutic Advances in Cardiovascular Disease style. No sign-up. |
| Publishes research in | Blood Pressure and Hypertension Studies Heart Failure Treatment and Management Atrial Fibrillation Management and Outcomes Coronary Interventions and Diagnostics Renin-Angiotensin System Studies |
| ISSN | 1753-9447 |
| Citation impact (2-yr) | 4.14 |
| h-index | 49 |
| i10-index | 286 |
| Total citations | 11,193 |
| Article processing charge | $2,000 |
| Open access | Yes |
| Top institutions publishing here | Wake Forest University |
| Journal website | us.sagepub.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Metabolic syndrome (MetS) represents a cluster of metabolic abnormalities that include hypertension, central obesity, insulin resistance, and atherogenic dyslipidemia, and is strongly associated with an increased risk for developing diabetes and atherosclerotic and nonatherosclerotic cardiovascular disease (CVD). The pathogenesis of MetS involves both genetic and acquired factors that contribute to the final pathway of inflammation…
Reduced functional ability and exercise tolerance in patients with heart failure (HF) are associated with poor quality of life and a worse prognosis. The 6-minute walking test (6MWT) is a widely available and well-tolerated test for the assessment of the functional capacity of patients with HF. Although the cardiopulmonary exercise test (a maximal exercise test)…
It is estimated that 10% of pregnancies are affected by hypertension worldwide. Approximately one-half of all hypertensive pregnancy disorders are due to preeclampsia, a pregnancy-specific disorder, its distinctive feature being either sudden onset, or worsening of pre-existing proteinuria. It has become increasingly recognized that women with a history of preeclampsia are at increased risk for…
The renin-angiotensin system (RAS) is a key component of cardiovascular physiology and homeostasis due to its influence on the regulation of electrolyte balance, blood pressure, vascular tone and cardiovascular remodeling. Deregulation of this system contributes significantly to the pathophysiology of cardiovascular and renal diseases. Numerous studies have generated new perspectives about a noncanonical and protective…
Left ventricular thrombus (LVT) complicates both ischemic and non-ischemic cardiomyopathies and is a potential cause of thromboembolic complications such as stroke. Management of LVT in the 21st century is primarily based on studies before the widespread use of potent pharmacological and interventional therapies such as primary percutaneous coronary intervention, especially in the setting of acute…
